Invest1 distinct publisher3 min readPublished
An 18,445-case cyclospora outbreak was the summer's loudest number, but the one that matters to anyone buying imported produce is 214: FDA foreign food inspections in two quarters, against 805 in all of fiscal 2024.
The Investor · Invest desk

Compiled by The InvestorSomething wrong?How this is made
A recall tally is an output of inspection activity, so the FDA citing its own falling numbers is a weaker rebuttal than it first looks: 1,836 recalls logged by early September, spread across the roughly eleven of twelve months elapsed in a fiscal year that closes on September 30, annualises to about 2,003, or 8% under fiscal 2024's 2,182 [9][10][4]. That is a real decline and a small one, and it happened in the same years the agency was doing less looking [5], which makes it two readings of one number rather than evidence for either.
The inspection arithmetic has no such ambiguity in it. Fortune's analysis of agency data puts fiscal 2025 foreign human food inspections about 10% below fiscal 2024 [5][1], and the 214 carried out in the first two quarters of fiscal 2026 implies a 428 annual pace, 53% of the 2024 count [2] and roughly 41% under the half-year rate fiscal 2025 was running [3]. Imported food is 20% of the US food supply [6]. Fortune attributes the slowdown not to fewer investigators but to the elimination of FDA support staff who booked inspector travel and carried out contamination testing [7], and the FDA says no investigators were affected by staffing changes or reductions in force [8]. That distinction is the whole mechanism: an administrative bottleneck is cheaper to reverse than a lost inspector cadre, and it is also cheaper to leave in place.
Two things cut against reading this as a clean chain from last year's DOGE cuts across the FDA, USDA and CDC [17] to this summer's outbreak. The GAO found in 2025 that the FDA has missed its domestic and foreign inspection targets every year since fiscal 2018, with the share of high-risk domestic facilities due for inspection that went uninspected running 7% in fiscal 2019, 40% in 2020 and 49% in 2021 [12], the last of those seven times the first [7]. And USDA says every federally regulated establishment still receives mandatory coverage every day, and that no FSIS-regulated product enters commerce without inspection [11]; if that holds, the 1,100-plus FSIS roles gone since 2024 [4] came out of everything except the line, and the headcount is not a food safety figure at all.
What the material does not contain is any account of who absorbs the cost. There is no claims data and no indemnity language in it, so a thesis about product recall cover repricing would be invention rather than analysis. The narrower point stands on published numbers: 18,445 cases since the start of May works out to about 145 a day [1][6], counted by the surveillance network HHS scaled down in August 2025 [13]. Of the two series, the recall count tells you how busy the agency is, and the case count told you what was in the lettuce, and it is the second one that stopped being mandatory [13].
Ranked by verification strength, evidence, and original report placement.
In July, Taylor Farms de Mexico recalled all iceberg lettuce sourced in Mexico from 27 states following a cyclospora outbreak that has sickened 18,445 people since the beginning of May.
According to Office of Personnel Management data, there are more than 1,100 fewer Food Safety and Inspection Service (FSIS) roles in the USDA since 2024.
A Fortune analysis of FDA data on foreign human food inspections found 805 inspections in fiscal 2024, 723 in fiscal 2025, and 214 in the first two quarters of fiscal 2026.
Imported food makes up 20% of the US food supply, and the FDA is carrying out fewer inspections of imported food.
The FDA told Fortune that the Trump administration is working closely with health departments across all 50 states to respond to outbreaks, and that no FDA investigators were impacted by staffing changes or reductions in force.
The FDA noted in a recent social media post that food recalls have decreased over the past few years, with 2,182 in fiscal 2024 and 2,160 in fiscal 2025, compared to 1,836 so far in fiscal 2026.
Distinct publishers with included, body-backed reporting in this cluster.
Follow any of these and your For You feed starts watching them — no settings page required.
leadership
Detection got faster than tracing, and the produce buyer now owns the recall1 distinct publisher
leadership
Summer's 17,000 cyclosporiasis cases move produce verification onto the buyer's books1 distinct publisher
product
Three Salmonella Outbreaks, One Failure Mode: Nobody Knew Where the Ingredient Went1 distinct publisher
science
Cyclosporiasis cases are easing, but one state's count is 95% of the national total1 distinct publisher
Evidence-backed comparisons of source perspectives and observed adoption signals. Read the methodology
Which Builder, Operator, and Investor concerns the observed source mix emphasized—not a truth score.
Evidence, demonstrated adoption, hype gap, incentives, and confidence are assessed independently, each on its own current evidence. How these are measured.
One outlet's tally, checkable documents beneath it
The inspection figures are Fortune's own read of FDA records, and nobody else in our coverage has run the same tally. Underneath them sit material a reader can pull independently: OPM headcount data, the GAO's 2025 review, the FDA's own recall post, and on-the-record statements from both agencies. The ceiling is set by the central figure of 214, extracted by a single outlet with no methodology given and no word on whether part-year inspection records are complete when counted.
Thick record of activity, no denominator
The countable side of this story is substantial: 214 foreign inspections in two quarters, more than 1,100 FSIS positions gone since 2024, six pathogens dropped from mandatory FoodNet surveillance, a lettuce recall reaching 27 states. These are events and headcounts, not projections. Where the record thins is precisely where the claim needs it, since no one has published inspections per import shipment, leaving the drop unmeasured against the volume of food actually crossing the border.
Counts firmer than the causation
Fortune chooses its verb carefully, saying the support-staff cuts correlate with the inspection drop, but the headline and Schaffner's warning invite a stronger causal read than the figures carry, and the GAO puts missed inspection targets back to 2018, six years before DOGE. Overstatement runs in the other direction too: the FDA's rebuttal leans on an unfinished fiscal year, and 1,836 recalls by 4 September annualise to about 8% below fiscal 2024, not the steeper fall the raw number suggests.
The defenders are also the subject
Both rebuttals come from the agencies whose staffing is the story, the FDA saying no investigators were touched and USDA saying daily plant coverage will not change, and the FDA's supporting number arrived as a social media post rather than a filing. The outside voices are academics whose fields depend on the surveillance and research budgets being cut. Fortune, meanwhile, is publishing its own dataset, which gives it authorship of the figure the piece is built around.
Single account, unfinished year
This rests on one publisher's dataset, in a fiscal year that still had close to four weeks to run when the piece appeared. The staffing figures and the GAO findings would hold up for anyone who went and looked; the fiscal 2026 inspection pace is the part most likely to move, whether because the second half catches up, which would take 509 inspections, or because early-year records were incomplete when pulled.